Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

German ban on Medtronic TAVI begins today, Edwards makes room for 'compassionate cases'

August 26, 2013 3:50 pm | by Mass Device | News | Comments

Starting today, medical device giant Medtronic is banned from selling its CoreValve and CoreValve Evolut transcatheter aortic valve implantation systems in Germany, thanks to a court ruling in favor of rival device maker Edwards Lifesciences.  

Reverse Medical lands FDA OK for micro vascular plug

August 23, 2013 11:29 am | by Mass Device | News | Comments

Irvine, Calif. medical device maker Reverse Medical Corp. touted FDA clearance for its flagship product, the MVP micro vascular plug for peripheral artery embolization. The plug helps decrease blood flow in the peripheral vasculature and is "completely re-sheathable" for use in procedures where a patient needs only temporary blood flow reduction.

Harvard Stem Cell Researchers Create Cells that Line Blood Vessels

August 23, 2013 10:08 am | by Harvard University | News | Comments

In a scientific first, Harvard Stem Cell Institute scientists have successfully grown the cells that line the blood vessels—called vascular endothelial cells—from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.

Advertisement

Technique May Help Regenerate Heart Cells to Treat Heart Disease

August 22, 2013 12:49 pm | by Mary Beth O'Leary, Cell Press | News | Comments

Researchers have developed a new technique that might one day be used to convert cells from heart disease patients into heart muscle cells that could act as a personalized treatment for their condition.        

What Is Your Heart Attack Risk?

August 22, 2013 9:57 am | by Albert Ang, Inderscience Publishers | News | Comments

Researchers in India have carried out a data mining exercise to determine which are the most important risk factors in increasing the chances of an individual suffering a heart attack. The use of computational data mining techniques that allow researchers to extract interesting and meaningful information from real-life clinical data could remove at least some aspect of the subjectivity of clinical prognosis.

Boston Scientific Receives FDA Approval For IntellaTip MiFi™ XP Ablation Catheter

August 22, 2013 9:51 am | by Boston Scientific Corporation | News | Comments

Boston Scientific Corporation continues to expand its electrophysiology (EP) offerings with U.S. Food and Drug Administration (FDA) approval of its IntellaTip MiFi™ XP catheter and 510(k) clearance of its Zurpaz™ 8.5F steerable sheath.

The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments

August 22, 2013 8:00 am | by PR Newswire | News | Comments

According to Millennium Research Group, the global authority on medical technology market intelligence, efforts to streamline the regulatory approval process in Japan have resulted in the recent entry of numerous devices in the Japanese peripheral vascular (PV) device market, and more products, such as drug-coated balloons and infrapopliteal stents, are expected to enter in the next few years.

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

August 19, 2013 6:02 pm | by PR Newswire | News | Comments

Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the SuperNOVA trial – a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and effectiveness of the Innova™ Self-Expanding Stent System (Innova Stent System). 

Advertisement

AngioDynamics Applauds National Institute for Health and Care Excellence's (NICE) Updated Guidelines for Varicose Vein Treatment

August 19, 2013 4:45 pm | by Globe Newswire | News | Comments

AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, applauds the decision by National Institute for Health and Care Excellence (NICE) to issue updated guidance for the treatment of varicose veins.

First German Patient enrolled pushes ROX Medical Past Halfway Point in CONTROL-HTN trial

August 19, 2013 4:26 pm | by PR Newswire | News | Comments

ROX Medical has crossed the halfway point in the CONTROL-HTN international, multi centre, randomized controlled hypertension trial. The milestone was met with the enrollment of the first patient from Prof. Markus van der Giet and Prof. Walter Zidek of the Charite Hospital, Benjamin Franklin Campus, Berlin.

JenaValve Announces First Implantations Of Transapical TAVI System In Canada

August 19, 2013 12:56 pm | by PR Newswire | News | Comments

JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today that it has successfully completed the first two implantations of its second-generation transapical JenaValve TAVI system in Canada.

Home Sensors Enable Seniors to Live Independently

August 19, 2013 10:29 am | by Ann Kellan, Science Nation Producer | News | Comments

People are living longer and they desire to live as independently as possible in their senior years. But, independent lifestyles come with risks, so researchers are developing "smart home" technologies like these to enhance and monitor ... 

Concept Animation of Nanorobotic Atherosclerosis Plaque Removal

August 15, 2013 9:47 am | by Nanobotmodels | Videos | Comments

Atherosclerosis is a major cardiovascular disease involving accumulations of lipids, white blood cells, and other materials on the inside of artery walls. Since the calcification found in the advanced stage of atherosclerosis dramatically enhances the mechanical properties of the plaque, restoring the original lumen of the artery remains a challenge.

Advertisement

Monitor Your Heart Rhythm Whenever, Wherever

August 14, 2013 3:21 pm | by Business Wire | News | Comments

SuperECG provides a 24-hour ECG examination for everyone. The HeartBug device is buttonless and the service functions completely online. The service has been developed by cardiologists and hardware and software designers. Now anyone can conduct a cardiac assessment that previously required a visit to a specialist.

Mouse Heart Beats Again with Human Cells

August 13, 2013 5:33 pm | by University of Pittsburgh Schools of the Health Sciences | News | Comments

A mouse heart was able to contract and beat again after its own cells were stripped and replaced with human heart precursor cells. The findings show the promise that regenerating a functional organ by placing human induced pluripotent stem cells in a three-dimensional scaffold could have for transplantation, drug testing models and understanding heart development.

Ambient Backscatter Eliminates Power Needs for Wireless Device Communication

August 13, 2013 5:18 pm | by University of Washington | Videos | Comments

University of Washington engineers have created a new wireless communication system that allows devices to interact with each other without relying on batteries or wires for power. The new communication technique, which the researchers call “ambient backscatter,” takes advantage of the TV and cellular transmissions that already surround us around the clock.

Wireless Devices Go Battery-Free with New Communication Technique

August 13, 2013 5:13 pm | by Michelle Ma, University of Washington | News | Comments

University of Washington engineers have created a new wireless communication system that allows devices to interact with each other without relying on batteries or wires for power. The new communication technique, which the researchers call “ambient backscatter,” takes advantage of the TV and cellular transmissions that already surround us around the clock.

Rapid Changes with Portable Medical Devices

August 13, 2013 2:05 pm | by Kirk Barker, Electronic Product Manager, maxon motors | Maxon Precision Motors, Inc. | Blogs | Comments

Kirk Barker, electronic product manager at maxon motors, was a part of the staff written article, “Portability Is the Name of the Game.” He took time to present a full array of responses that were not able to be included in the article, so they are presented here.

GPOs: Medtronic, St. Jude, Boston Scientific land new deals from Premier

August 13, 2013 12:27 pm | by Mass Device | News | Comments

Premier Healthcare Alliance awarded several new contracts for drug-eluting stents, traditional stents and other intervention products to 8 heavy hitters in the cardiology space. Abbott, Boston Scientific, and Medtronic all landed supplier deals for drug-eluting and traditional stents.

Meeting Notice: September 11-12, 2013 Circulatory System Devices Panel of the Medical Devices Advisory Committee

August 13, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

On September 11, 2013, during session I, the committee will discuss and make recommendations regarding the proposed classification of external cardiac compressor (ECC) devices, one of the remaining preamendments class III devices regulated under the section 510(k) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360(k)) (510(k)) pathway. 

Medicomp Introducing New Wireless Cardiac Technology

August 9, 2013 2:10 pm | by Bio-Medicine.Org | News | Comments

Medicomp, Inc. introduces the SAVI Air, the only Wireless Event Monitor to offer beat-to-beat analysis of the entire ECG, a patented feature previously unavailable to healthcare. Prior to the release of the SAVI Air, wireless event monitors relied on algorithms that could only analyze limited aspects of the ECG, therefore increasing the risk of missing significant arrhythmias.

Abbott’s Investigational Absorb Bioresorbable Scaffold Recognized in R&D 100

August 9, 2013 12:31 pm | by Abbott | News | Comments

Abbott’s investigational Absorb™ Bioresorbable Vascular Scaffold was recently named one of R&D Magazine’s 2013 top 100 technologies as part of its 51st annual R&D 100 Awards. Absorb joins a number of innovative technologies being honored by the awards, which recognize the 100 most technologically significant products introduced into the marketplace over the past year.

George W. Bush Heart Surgery Will Drive Misguided US Stenting Trend, Says GlobalData

August 9, 2013 11:30 am | by GlobalData | News | Comments

Former President George W. Bush’s recent heart stent operation will further increase the popularity of what is often an unnecessary and wasteful procedure, says an analyst with research and consulting firm GlobalData. The ex-US President received a stent to prop open a clogged coronary artery on Tuesday morning, following a regularly scheduled visit to his doctor.

Robot Uses Steerable Needles to Treat Brain Clots

August 9, 2013 10:38 am | by David Salisbury | News | Comments

Surgery to relieve the damaging pressure caused by hemorrhaging in the brain is a perfect job for a robot. That is the basic premise of a new image-guided surgical system under development at Vanderbilt University. It employs steerable needles about the size of those used for biopsies to penetrate the brain with minimal damage and suction away the blood clot that has formed.

Heart attack survival rates higher in gyms, study says

August 9, 2013 7:29 am | by Mass Device | News | Comments

Surviving sudden cardiac arrest depends largely on the people around you and easy access to an automated defibrillator, or AED. It turns out that the gym is the best indoor location for cardiac arrest victims' survival chances, likely because of the increased presence of AEDs and well-placed instruction manuals.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading